HIV-related hematological malignancies: A concise review

Clinical Lymphoma, Myeloma and Leukemia

Volumn 14, Issue , 2014, Pages S96-S103

  Rios, Adan ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

AIDS; DA EPOCH chemotherapy; HAART; Non Hodgkin's lymphoma; PCNS lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; HEMATOLOGIC MALIGNANCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LYMPHOMA; NONHODGKIN LYMPHOMA; PANDEMIC; PATHOGENESIS; COMPLICATION; HEMATOLOGIC NEOPLASMS; HIV INFECTIONS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEMATOLOGIC NEOPLASMS; HIV INFECTIONS; HUMANS;

EID: 84939423478     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2014.06.020     Document Type: Conference Paper

References (79)

1. K.A. Sepkowitz AIDS - the first 20 years N Engl J Med 344 2001 1764 1772
2. R.S. Hogg, K.V. Heath, B. Yip, and et al. Improved survival among HIV-infected individuals following initiation of anti-retroviral therapy JAMA 279 1998 450 454
3. Veneman A. Point of view: child survival in Africa - seven signs of hope. UNICEF Press Centre May 28, 2008. Available at: http://www.unicef.org/media/index-44202.html. Accessed July 19, 2014.
4. R.J. Biggar, K. Anil, A.K. Chaturvedi, and et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS J Natl Cancer Inst 99 2007 962 972
5. C. Palmieri, T. Treibel, O. Large, and et al. AIDS-related non-Hodgkin lymphoma in the first decade of highly active antiretroviral therapy Q J Med 99 2006 811 826
6. E.A. Mesri, M.A. Feitelson, and K. Munger Human viral oncogenesis: a cancer hallmark analysis Cell Host Microbe 15 2014 266 282
7. J. Stebbing, O. Duru, and M. Bower Non-AIDS-defining cancers Curr Opin Infect Dis 22 2009 7 10
8. P.G. Rubinstein, D.M. Aboulafia, and A. Zloza Malignacies in HIV\AIDS: from epidemiology to therapeutic challenges AIDS 28 2014 453 465
9. A. Rios, and F. Heigemaster AIDS-related malignancies The M.D. Anderson Manual of Medical Oncology 2011 The McGraw-Hill Companies, Inc USA 1141 1171
10. Centers for Disease Control (CDC) Pneumocystis pneumonia-Los Angeles MMWR Morb Mortal Wkly Rep 30 1981 250 252
11. Centers for Disease Control (CDC) Kaposi's sarcoma and pneumocystis pneumonia among homosexual men - New York City and California MMWR Morb Mortal Wkly Rep 30 1981 305 308
12. L. Morison The global epidemiology of HIV/AIDS Br Med Bull 58 2001 7 18
13. M.S. Gottlieb AIDS-past and future N Engl J Med 344 2001 1788 1791
14. S.M. Hammer Management of newly diagnosed HIV infection N Engl J Med 353 2005 1701 1710
15. E.R. Stiehm, T.W. Chin, A. Hass, and et al. Infectious complications of the primary immunodeficiencies Clin Immunol Immunopathol 40 1986 69 86
16. D. Farge, C. Lebbé, Z. Marjanovic, and et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients1. Groupe Cooperatif de Transplantation d'Ile de France (GCIF) Transplantation 67 1999 1236 1242
17. F. Barré-Sinoussi, J.C. Chermann, F. Rey, and et al. Isolation of a T-lymphoytopic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 1983 868 871
18. B.H. Hahn, G.M. Shaw, K.M. De Cock, and et al. AIDS as a zoonosis: scientific and public health implications Science 287 2000 607 614
19. F. Gao, E. Bailes, D.L. Robertson, and et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes Nature 397 1999 436 441
20. Z. Chen, P. Telfer, A. Gettie, and et al. Genetic characterization of new West African simian immunodeficiency virus SIVsm: Geographic custering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop J Virol 70 1996 3617 3627
21. K.M. De Cock, G. Adjorlolo, E. Ekpini, and et al. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic JAMA 270 1993 2083 2086
22. P. Kahn Do clades matter for HIV vaccines? IAVI Rep 7 2003; May-August
23. UNAIDS Word AIDS Day Report. Results 2012. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/JC2434-WorldAIDSday-results-en.pdf. Accessed July 19, 2014.
24. M.P. Kieny Structure and regulation of the human AIDS virus J Acquir Immune Defic Syndr 3 1990 395 402
25. C.L. Althaus, A.S. De Vos, and R.J. De Boer Reassessing the human immunodeficiency virus type 1 life cycle through age-structured modeling: life span of infected cells, viral generation time, and basic reproductive number, R0 J Virol 15 2009 7659 7667
26. D.D. Ho, U. Avidan, A.U. Neeumann, and et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123 126
27. R.S. Veazey, and A.A. Lackner Getting to the guts of HIV pathogenesis J Exp Med 200 2004 697 700
28. + T cell depletion and viral replication in SIV infection Science 280 1998 427 431
29. M.L. Santiago, M. Montano, R. Benitez, and et al. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection Science 321 2008 1343 1346
30. P.C. Angeletti, L. Zhang, and C. Wood The viral etiology of AIDS-associated malignancies Adv Pharmacol 56 2008 509 557
31. R.J. Biggar, E.A. Engels, and M. Frisch Risks of T-cell lymphomas in persons with AIDS J AIDS 26 2001 371 376
32. N.S. Shiels, R.M. Pfeiffer, M.H. Gail, and et al. Cancer burden in the HIV infected population in the USA J Natl Cancer Inst 103 2011 753 762
33. S.H. Swerdlow, E.S. Jaffe, International Agency for research on Cancer, and World Health Organization WHO Classification of Tumors of Haemotopoietic and Lymphoid Tissues 2008 International Agency for Research on Cancer Lyon 340 342
34. L.R. Barclay, S.E. Buskin, E.M. Kahle, and et al. Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy Clin Lymphoma Myeloma 4 2007 272 279
35. A. Carbone, and A. Gloghini AIDS-related lymphomas: from pathogenesis to pathology Br J Haematol 130 2005 662 670
36. C.M. Vajdic, and M.T. van Leeuwen What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients Curr Opin HIV/AIDS 1 2009 35 41
37. Y. Chang, E. Cesarman, M.S. Pessin, and et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
38. A. Carbone, E. Cesarman, M. Spina, and et al. HIV-associated lymphomas and gamma-herpesviruses Blood 113 2009 1213 1224
39. R. Longnecker Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv Cancer Res 79 2000 175 200
40. P. Vaghefi, A. Martin, S. Prévot, and et al. Genomic imbalances in AIDS-related lymphomas: relation with tumoral Epstein-Barr virus status AIDS 20 2006 2285 2291
41. E. Cesarman Pathology of lymphoma in HIV Curr Opin Oncol 25 2013 487 494
42. D.M. Knowles Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma Semin Diagn Pathol 1 1997 67 82
43. K.V. Voelkerding, L.M. Sandhaus, H.C. Kim, and et al. Plasma cell malignancy in the acquired immune deficiency syndrome Am J Clin Pathol 92 1989 222 228
44. A.M. Levine, S. Sadeghi, B. Espina, and et al. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection Cancer 94 2002 1500 1506
45. J. Goldstein, N. Becker, J. Delrowe, and et al. Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1. Use of radiation therapy Cancer 66 1990 1130 1132
46. A.M. Tsimberidou, J. Medina, J. Cortes, and et al. Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature Leuk Res 6 2004 657 660
47. K. Dunleavy, R.F. Little, S. Pittaluga, and et al. The role of tumor histogenesis, FDG-PET and short course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV associated diffuse large B cell lymphoma Blood 115 2010 3017 3024
48. J.L. Ziegler, J.A. Beckstead, P.A. Volberding, and et al. Non-Hodgkin lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome N Engl J Med 311 1984 565 570
49. G. Rossi, A. Donisi, S. Casari, and et al. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma Cancer 86 1999 2391 2397
50. D. Francisci, F. Falcinelli, E. Schiaroli, and et al. Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy Infection 38 2010 58 61
51. L.D. Kaplan, D.J. Straus, M.A. Testa, and et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group N Engl J Med 336 1997 1641 1648
52. A.M. Levine Management of AIDS-related lymphoma Curr Opin Oncol 20 2008 522 528
53. C. Wyen, B. Jensen, M. Hentrich, and et al. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients AIDS 26 2012 457 464
54. J.A. Sparano, E. Weller, T. Nazeer, and et al. Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493) Blood 100 2002 1634 1640
55. R.F. Little, S. Pittaluga, N. Grant, and et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology Blood 101 2003 4653 4659
56. J. Cortes, D. Thomas, A. Rios, and et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia Cancer 94 2002 1492 1499
57. E.S. Wang, D.J. Straus, J. Teruya-Feldstein, and et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus associated Burkitt lymphoma Cancer 98 2003 1196 1205
58. K. Dunleavy, S. Pittaluga, M. Shovlin, and et al. Low-intensity therapy in adults with Burkitt lymphoma N Engl J Med 369 2013 1915 1925
59. A. Krishnan, A. Molina, J. Zaia, and et al. Durable remissions with autologous stem cell transplantation for high risk HIV associated lymphomas Blood 105 2004 874 878
60. T.R. Spitzer, R.F. Ambinder, J.Y. Lee, and et al. Dose reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus associated lymphomas: AIDS Malignancy Consortium Study 020 Biol Blood Marrow Transplant 14 2008 59 66
61. S.K. Barta, X. Xue, D. Wang, and et al. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients Blood 122 2013 3251 3262
62. Y.L. Kasamon, and R.F. Ambinder AIDS-related primary central nervous system lymphoma Hematol Oncol Clin North Am 19 2005 665 687 vi-vii
63. A. Cingolani, L. Fratino, G. Scopettuolo, and et al. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era J Neurovirol 11 suppl 3 2005 38 44
64. A.B. Rickinson, and E. Kieff Epstein-Barr virus B.N. Fields, D.M. Knipe, P.M. Howley, Virology III ed 1996 Lippincott-Raven Philadelphia 2397 2446
65. S.Y. Wong, D.M. Israeliski, and J.S. Remington AIDS-associated toxoplasmosis M.A. Sande, P.A. Volberding, The Medical Management of AIDS 4th ed 1995 WB Saunders Philadelphia 460
66. M. Lorberboym, F. Wallach, L. Estok, and et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients J Nucl Med 39 1998 1366 1369
67. J.E. Broomberg, D.A. Breems, J. Kran, and et al. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies Neurology 68 2007 1674 1679
68. G.D. Shah, J. Yahalom, D.D. Correa, and et al. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma J Clin Oncol 25 2007 4730 4735
69. M.C. Chamberlain, and S.K. Johnston High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma Neuro Oncol 12 2010 736 744
70. A. Carbone, A. Gloghini, D. Serraino, and et al. HIV-associated Hodgkin lymphoma Curr Opin HIV/AIDS 4 2009 3 10
71. A. Carbone, A. Gloghini, and G. Dotti EBV-associated lymphproliferative disorders: classification and treatment Oncologist 13 2008 577 585
72. A.M. Levine Commentary: Hodgkin lymphoma: to the HAART of the matter Blood 108 2006 3630
73. M. Guiguet, F. Boné, J. Cadranel, and et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study Lancet Oncol 10 2009 1152 1159
74. E. Vaccher, M. Spina, and U. Tirelli Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals Eur J Cancer 37 2001 1306 1315
75. A.M. Levine, P. Li, T. Cheung, and et al. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149) J AIDS 15 2000 444 450
76. P. Hartmann, U. Rehuwald, B. Salzberg, and et al. BEACOPP therapeutic regimen for patients with Hodgkin disease and HIV infection Ann Oncol 14 2003 1562 1569
77. M. Spina, J. Gabarre, and G. Rossi Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection Blood 100 2002 1984 1988
78. L. Kaplan Management of HIV-associated Hodgkin lymphoma: how far we have come J Clin Oncol 30 2012 4056 4058
79. M.E. Valencia Ortega AIDS-related malignancies-a new approach AIDS Rev 10 2008 125 127